Published in Mod Pathol on August 01, 2004
Knowledge discovery processing and data mining in karyometry. Anal Quant Cytol Histol (2009) 0.87
Vitamin D metabolism and action in the prostate: implications for health and disease. Mol Cell Endocrinol (2011) 0.86
Use of 1,25α dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model. Prostate Cancer Prostatic Dis (2011) 0.76
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Effect of dutasteride on the risk of prostate cancer. N Engl J Med (2010) 12.78
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet (2002) 9.71
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet (2006) 9.17
A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet (2009) 8.30
Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet (2006) 7.72
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet (2006) 6.67
2004 WHO classification of the renal tumors of the adults. Eur Urol (2006) 4.85
Are current health behavioral change models helpful in guiding prevention of weight gain efforts? Obes Res (2003) 3.62
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA (2006) 3.32
The use of morphological characteristics and texture analysis in the identification of tissue composition in prostatic neoplasia. Hum Pathol (2004) 2.94
The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol (2007) 2.70
Cystic nephroma and mixed epithelial and stromal tumour of the kidney: opposite ends of the spectrum of the same entity? Eur Urol (2007) 2.33
Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. J Clin Oncol (2009) 2.30
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nat Genet (2013) 2.29
Immunoglobulin G4-related disease in genitourinary organs: an emerging fibroinflammatory entity often misdiagnosed preoperatively as cancer. Eur Urol (2012) 2.18
Variability in diagnostic opinion among pathologists for single small atypical foci in prostate biopsies. Am J Surg Pathol (2010) 2.16
Words of wisdom: re: multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Eur Urol (2013) 2.00
School-based obesity prevention: a blueprint for taming the epidemic. Am J Health Behav (2002) 1.99
An array microscope for ultrarapid virtual slide processing and telepathology. Design, fabrication, and validation study. Hum Pathol (2004) 1.98
Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer. Clin Cancer Res (2005) 1.90
Mutations in the gene encoding the Sigma 2 subunit of the adaptor protein 1 complex, AP1S2, cause X-linked mental retardation. Am J Hum Genet (2006) 1.85
RAD51C is a susceptibility gene for ovarian cancer. Hum Mol Genet (2011) 1.80
Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nat Genet (2011) 1.77
Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens. Am J Surg Pathol (2008) 1.72
Neuroendocrine tumours of the urinary system and male genital organs: clinical significance. BJU Int (2009) 1.71
A pilot study of compositional analysis of the breast and estimation of breast mammographic density using three-dimensional T1-weighted magnetic resonance imaging. Cancer Epidemiol Biomarkers Prev (2008) 1.70
Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial. J Urol (2007) 1.69
Histological changes of minimally invasive procedures for the treatment of benign prostatic hyperplasia and prostate cancer: clinical implications. J Urol (2003) 1.68
Evaluating the effectiveness of using standard mammogram form to predict breast cancer risk: case-control study. Cancer Epidemiol Biomarkers Prev (2008) 1.66
2005 update on pathology of prostate biopsies with cancer. Eur Urol (2006) 1.66
IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet (2005) 1.62
A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk. Hum Mol Genet (2013) 1.52
Original Gleason system versus 2005 ISUP modified Gleason system: the importance of indicating which system is used in the patient's pathology and clinical reports. Eur Urol (2010) 1.51
Histone acetylation and chromatin pattern in cancer. A review. Anal Quant Cytol Histol (2007) 1.51
Carcinogenesis and the hypothesis of phylogenetic reversion. Anal Quant Cytol Histol (2006) 1.47
Biopsy misidentification identified by DNA profiling in a large multicenter trial. J Clin Oncol (2011) 1.44
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression. Mod Pathol (2002) 1.43
2009 update on the classification of renal epithelial tumors in adults. Int J Urol (2009) 1.43
What does the urologist expect from the pathologist (and what can the pathologists give) in reporting on adult kidney tumour specimens? Eur Urol (2006) 1.42
Immunohistochemical expression of endothelin-1 and endothelin-A and endothelin-B receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer. Eur Urol (2007) 1.39
Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy. Virchows Arch (2007) 1.39
Classification and reclassification of adult renal epithelial tumors. Anal Quant Cytol Histol (2008) 1.38
Rare and unusual histological variants of prostatic carcinoma: clinical significance. BJU Int (2008) 1.36
Prostatic stromal hyperplasia with atypia: follow-up study of 18 cases. Arch Pathol Lab Med (2008) 1.33
Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. Diagn Pathol (2014) 1.26
Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysis. Radiology (2005) 1.24
Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007. Pathology (2007) 1.24
Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. Arch Pathol Lab Med (2007) 1.23
High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice. Am J Surg Pathol (2005) 1.20
Karyometry of the colonic mucosa. Cancer Epidemiol Biomarkers Prev (2007) 1.20
Staging of prostate cancer. Histopathology (2012) 1.19
High-grade prostatic intraepithelial neoplasia. Rev Urol (2004) 1.18
Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases. J Urol (2012) 1.16
Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate. Mod Pathol (2006) 1.15
Karyometry of nuclei from actinic keratosis and squamous cell cancer of the skin. Anal Quant Cytol Histol (2003) 1.14
Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful? Arch Pathol Lab Med (2012) 1.12
Solitary fibrous tumour of the prostate identified on needle biopsy. Eur Urol (2009) 1.09
Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007. Urology (2007) 1.09
Adenoid cystic/basal cell carcinoma of the prostate: clinicopathologic findings in 19 cases. Am J Surg Pathol (2003) 1.08
Determination of a minimal deletion interval on chromosome band 8p21 in sporadic prostate cancer. Genes Chromosomes Cancer (2002) 1.07
Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potential. Cell Oncol (2007) 1.06
Mammographic density, estrogen receptor status and other breast cancer tumor characteristics. Breast J (2010) 1.06
SEPT9_v4 expression induces morphological change, increased motility and disturbed polarity. J Pathol (2005) 1.05
Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approach. Urology (2007) 1.05
Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate. Nat Clin Pract Urol (2007) 1.05
Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model. Carcinogenesis (2005) 1.04
A model of goal directed vegetable parenting practices. Appetite (2011) 1.04
Needle core length in sextant biopsy influences prostate cancer detection rate. Urology (2002) 1.04
TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia. J Clin Oncol (2013) 1.03
Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach. Cancer Epidemiol Biomarkers Prev (2006) 1.03
Implications of the International Society of Urological Pathology modified Gleason grading system. Arch Pathol Lab Med (2012) 1.03
Process evaluation results from the HEALTHY physical education intervention. Health Educ Res (2011) 1.02
Defining the Optimal Selenium Dose for Prostate Cancer Risk Reduction: Insights from the U-Shaped Relationship between Selenium Status, DNA Damage, and Apoptosis. Dose Response (2009) 1.02
Prostate biopsy and optimization of cancer yield. Eur Urol (2006) 1.02
Genome-wide association study identifies a possible susceptibility locus for endometrial cancer. Cancer Epidemiol Biomarkers Prev (2012) 1.02
Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant? Am J Clin Pathol (2009) 1.02
The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer. Histopathology (2014) 1.01
Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis. Diagn Mol Pathol (2003) 1.00
Familial relative risks for breast cancer by pathological subtype: a population-based cohort study. Breast Cancer Res (2010) 1.00
Secondary neoplasms of the urinary system and male genital organs. BJU Int (2009) 1.00
Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate. Am J Pathol (2004) 0.99
Urethral caruncle: clinicopathologic features of 41 cases. Hum Pathol (2012) 0.99